Protective effect of Dammarane Sapogenins against chemotherapy-induced myelosuppression in mice

Experimental Biology and Medicine

Volumn 236, Issue 6, 2011, Pages 729-735

  Yang, Yanyan ^a   Xu, Shuping ^a   Xu, Qiuxia ^a   Liu, Xinmin ^a,d   Gao, Yue ^b   Steinmetz, Andre ^c   Wang, Ning ^c   Wang, Tianshan ^d   Qiu, Guosong ^d  

^a INSTITUTE OF MEDICINAL PLANT DEVELOPMENT   (China)

^b BEIJING INSTITUTE OF RADIATION MEDICINE   (China)

^c LUXEMBOURG INSTITUTE OF HEALTH   (Luxembourg)

^d Pegasus Pharmaceuticals Group Inc   (Canada)

Author keywords

Cyclophosphamide; Dammarane sapogenins; Hematopoiesis; Immunoregulation; Myelosuppression; Splenocyte proliferation

Indexed keywords

CYCLOPHOSPHAMIDE; DAMMARANE DERIVATIVE; EOSIN; GINSENG EXTRACT; HEMATOXYLIN; LIPOPOLYSACCHARIDE; PLANT EXTRACT; SAPOGENIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE MARROW SUPPRESSION; BURST FORMING UNIT E; CELL PROLIFERATION; COLONY FORMING UNIT E; COLONY FORMING UNIT GEMM; COLONY FORMING UNIT GM; CONTROLLED STUDY; ERYTHROCYTE COUNT; FEMUR; GINSENG; HEMATOPOIESIS; LEUKOCYTE COUNT; MALE; MEGAKARYOCYTE; MOUSE; NONHUMAN; SPLEEN CELL; STAINING; THROMBOCYTE COUNT; THYMUS;

ADMINISTRATION, ORAL; ANIMALS; COLONY-FORMING UNITS ASSAY; CYCLOPHOSPHAMIDE; DRUG THERAPY; FEMUR; HISTOCYTOCHEMISTRY; LEUKOCYTE COUNT; MICE; MYELOABLATIVE AGONISTS; PANAX; PROTECTIVE AGENTS; SAPOGENINS; STEM CELLS; TRITERPENES;

MUS; PANAX GINSENG;

EID: 79958844512     PISSN: 15353702     EISSN: 15353699     Source Type: Journal    
DOI: 10.1258/ebm.2011.010369     Document Type: Article

References (41)

1. Takano F, Tanaka T, Aoi J, Yahagi N, Fushiya S. Protective effect of (+)-catechin against 5-fluorouracil-induced myelosuppression in mice. Toxicology 2004;201:133-142
2. Ayhanci A, Gunes S, Sahinturk V, Appak S, Uyar R, Cengiz M, Altuner Y, Yaman S. Seleno L-methionine acts on cyclophosphamide-induced kidney toxicity. Biol Trace Elem Res 2010;136:171-179
3. Gomez Raposo C, Pinto Marin A, Gonzalez Baron M. Colony-stimulating factors: clinical evidence for treatment and prophylaxis of chemotherapy-induced febrile neutropenia. Clin Transl Oncol 2006;8:729-734
4. Liang DC. The role of colony-stimulating factors and granulocyte transfusion in treatment options for neutropenia in children with cancer. Paediatr Drugs 2003;5:673-684
5. Stern AC, Jones TC. The side-effect profile of GM-CSF. Infection 1992;20 (Suppl 2):S124-S127
6. Lutzky J, Weber R, Nunez Y, Gillett M, Spitler L. A phase 1 study of granulocyte macrophage colony-stimulating factor (sargramostim) and escalating doses of thalidomide in patients with high-risk malignant melanoma. J Immunother 2009;32:79-85
7. Geissler RG, Ganser A. Myelodysplastic syndromes: a guide to treatment with epoetin and colony-stimulating factors. BioDrugs 1998;10:97-109
8. Yu JL, Dou DQ, Chen XH, Yang HZ, Guo N, Cheng GF. Protopanaxatriol-type ginsenosides differentially modulate type 1 and type 2 cytokines production from murine splenocytes. Planta Med 2005;71:202-207
9. Lee SY, Kim GT, Roh SH, Song JS, Kim HJ, Hong SS, Kwon SW, Park JH. Proteomic analysis of the anti-cancer effect of 20S-ginsenoside Rg3 in human colon cancer cell lines. Biosci Biotechnol Biochem 2009;73:811-816
10. Wang Q, Sun LH, Jia W, Liu XM, Dang HX, Mai WL, Wang N, Steinmetz A, Wang YQ, Xu CJ. Comparison of ginsenosides Rg1 and Rb1 for their effects on improving scopolamine-induced learning and memory impairment in mice. Phytother Res 2010;24:1748-1754
11. Cheng Y, Shen LH, Zhang JT. Anti-amnestic and anti-aging effects of ginsenoside Rg1 and Rb1 and its mechanism of action. Acta Pharmacol Sin 2005;26:143-149
12. Cho S, Won CH, Lee DH, Lee MJ, Lee S, So SH, Lee SK, Koo BS, Kim NM, Chung JH. Red ginseng root extract mixed with Torilus fructus and Corni fructus improves facial wrinkles and increases type I procollagen synthesis in human skin: a randomized, double-blind, placebo-controlled study. J Med Food 2009;12:1252-1259
13. Attele A, Wu J, Yuan C. Ginseng pharmacology multiple constituents and multiple actions. Biochemical Pharmacology 1999;58:1685-1693
14. Maslov LN, Konkovskaia Iu N. [Inotropic, cardioprotective and antiarrhythmic effects of ginseng preparations]. Eksp Klin Farmakol 2009;72:52-60
15. Tawab MA, Bahr U, Karas M, Wurglics M, Schubert-Zsilavecz M. Degradation of ginsenosides in humans after oral administration. Drug Metab Dispos 2003;31:1065-1071
16. Hasegawa H. Proof of the mysterious efficacy of ginseng: basic and clinical trials: metabolic activation of ginsenoside: deglycosylation by intestinal bacteria and esterification with fatty acid. J Pharmacol Sci 2004;95:153-157
17. Bae EA, Han MJ, Kim EJ, Kim DH. Transformation of ginseng saponins to ginsenoside Rh2 by acids and human intestinal bacteria and biological activities of their transformants. Arch Pharm Res 2004;27:61-67
18. Hasegawa H, Lee KS, Nagaoka T, Tezuka Y, Uchiyama M, Kadota S, Saiki I. Pharmacokinetics of ginsenoside deglycosylated by intestinal bacteria and its transformation to biologically active fatty acid esters. Biol Pharm Bull 2000;23:298-304
19. Zhang JT. The Chemistry, Metabolism and Biological Activities of Ginseng. Beijing: Chemical Industry Press, 2006
20. Liu Y, Zhang JW, Li W, Ma H, Sun J, Deng MC, Yang L. Ginsenoside metabolites, rather than naturally occurring ginsenosides, lead to inhibition of human cytochrome P450 enzymes. Toxicol Sci 2006;91:356-364
21. Popovich DG, Kitts DD. Structure-function relationship exists for ginsenosides in reducing cell proliferation and inducing apoptosis in the human leukemia (THP-1) cell line. Arch Biochem Biophys 2002;406:1-8
22. Bae EA, Park SY, Kim DH. Constitutive beta-glucosidases hydrolyzing ginsenoside Rb1 and Rb2 from human intestinal bacteria. Biol Pharm Bull 2000;23:1481-1485
23. Sun LH, Wang Q, Liu XM, Brons NH, Wang N, Steinmetz A, Lv YL, Liao YH, Zheng HY. Anti-cancer effects of 20(S)-protopanoxadiol on human acute lymphoblastic leukemia cell lines Reh and RS4;11. Med Oncol 2010 [Epub ahead of Print]
24. Yim HW, Jong HS, Kim TY, Choi HH, Kim SG, Song SH, Kim J, Ko SG, Lee JW, Bang YJ. Cyclooxygenase-2 inhibits novel ginseng metabolite-mediated apoptosis. Cancer Res 2005;65:1952-1960
25. Shim GJ, Wang L, Andersson S, Nagy N, Kis LL, Zhang Q, Makela S, Warner M, Gustafsson JA. Disruption of the estrogen receptor beta gene in mice causes myeloproliferative disease resembling chronic myeloid leukemia with lymphoid blast crisis. Proc Natl Acad Sci USA 2003;100:6694-6699
26. Gregory MS, Duffner LA, Faunce DE, Kovacs EJ. Estrogen mediates the sex difference in post-burn immunosuppression. J Endocrinol 2000;164:129-138
27. Welte K, Bonilla MA, Gabrilove JL, Gillio AP, Potter GK, Moore MA, O'Reilly RJ, Boone TC, Souza LM. Recombinant human granulocyte-colony stimulating factor: in vitro and in vivo effects on myelopoiesis. Blood Cells 1987;13:17-30
28. Mayer P, Schutze E, Lam C, Kricek F, Liehl E. Recombinant murine granulocyte-macrophage colony-stimulating factor augments neutrophil recovery and enhances resistance to infections in myelosuppressed mice. J Infect Dis 1991;163:584-590
29. Alberts DS. Protection by amifostine of cyclophosphamide-induced myelosuppression. Semin Oncol 1999;26:37-40
30. Sun HX, Peng XY. Protective effect of triterpenoid fractions from the rhizomes of Astilbe chinensis on cyclophosphamide-induced toxicity in tumor-bearing mice. J Ethnopharmacol 2008;119:312-317
31. Digiulio M, Keogh J, Jackson D. Medical-Surgical Nursing Demystified. New York: McGraw-Hill Professional, 2008
32. Ellefson DD, di Zerega GS, Espinoza T, Roda N, Maldonado S, Rodgers KE. Synergistic effects of co-administration of angiotensin 1-7 and Neupogen on hematopoietic recovery in mice. Cancer Chemother Pharmacol 2004;53:15-24
33. Shim JY, Han Y, Ahn JY, Yun YS, Song JY. Chemoprotective and adjuvant effects of immunomodulator ginsan in cyclophosphamide-treated normal and tumor bearing mice. Int J Immunopathol Pharmacol 2007;20:487-497
34. Kaneko M, Kawakita T, Kumazawa Y, Takimoto H, Nomoto K, Yoshikawa T. Accelerated recovery from cyclophosphamide-induced leukopenia in mice administered a Japanese ethical herbal drug, Hochu-ekki-to. Immunopharmacology 1999;44:223-231
35. Travlos GS. Normal structure, function, and histology of the bone marrow. Toxicol Pathol 2006;34:548-565
36. Mahiou J, Walter U, Lepault F, Godeau F, Bach JF, Chatenoud L. In vivo blockade of the Fas-Fas ligand pathway inhibits cyclophosphamide-induced diabetes in NOD mice. J Autoimmun 2001;16:431-440
37. Santosuosso M, Divangahi M, Zganiacz A, Xing Z. Reduced tissue macrophage population in the lung by anticancer agent cyclophosphamide: restoration by local granulocyte macrophage-colony-stimulating factor gene transfer. Blood 2002;99:1246-1252
38. Suntararuks S, Yoopan N, Rangkadilok N, Worasuttayangkurn L, Nookabkaew S, Satayavivad J. Immunomodulatory effects of cadmium and Gynostemma pentaphyllum herbal tea on rat splenocyte proliferation. J Agric Food Chem 2008;56:9305-9311
39. Cerqueira F, Cordeiro-Da-Silva A, Gaspar-Marques C, Simoes F, Pinto MM, Nascimento MS. Effect of abietane diterpenes from Plectranthus grandidentatus on T- and B-lymphocyte proliferation. Bioorg Med Chem 2004;12:217-223
40. Eric Gershwin M, Vierling JM, Manns MP. Liver Immunology: Principles and Practice. New York: Humana Press, 2007
41. Wang L, Zhao N, Zhang F, Yue W, Liang M. Effect of taurine on leucocyte function. Eur J Pharmacol 2009;616:275-280